Cronos Group Inc.
CRON- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001656472
No open-market purchases or sales by Cronos Group Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $133.7M in total; no superinvestor holds it.
Holders of 5% or more of CRON
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cronos Group Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cronos Group Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Cronos Group Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 25, 20246:39 PM ET | Altria Group, Inc. | 13D/AOld format | – | – | – | SEC |
| Dec 19, 20228:47 AM ET | Altria Group, Inc. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cronos Group Inc. shares.
No Form 144 notices for Cronos Group Inc. are on file.